Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Management dilemmas in acute pulmonary embolism.

Condliffe R, Elliot CA, Hughes RJ, Hurdman J, Maclean RM, Sabroe I, van Veen JJ, Kiely DG.

Thorax. 2014 Feb;69(2):174-80. doi: 10.1136/thoraxjnl-2013-204667. Epub 2013 Dec 16. Review.

2.

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.

Bowyer AE, Van Veen JJ, Goodeve AC, Kitchen S, Makris M.

Haematologica. 2013 Dec;98(12):1980-7. doi: 10.3324/haematol.2013.088088. Epub 2013 Jun 28.

3.

Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.

van Veen JJ, Smith J, Kitchen S, Makris M.

Br J Haematol. 2013 Mar;160(6):859-61. doi: 10.1111/bjh.12173. Epub 2012 Dec 29. No abstract available.

PMID:
23278675
4.

Guideline on the management of bleeding in patients on antithrombotic agents.

Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M; British Committee for Standards in Haematology.

Br J Haematol. 2013 Jan;160(1):35-46. doi: 10.1111/bjh.12107. Epub 2012 Nov 1. No abstract available.

PMID:
23116425
5.

Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.

Toth P, van Veen JJ, Robinson K, Maclean RM, Hampton KK, Laidlaw S, Makris M.

Blood Transfus. 2013 Oct;11(4):500-5. doi: 10.2450/2012.0113-12. Epub 2012 Oct 10.

6.

Protamine reversal of low molecular weight heparin: clinically effective?

van Veen JJ, Maclean RM, Hampton KK, Laidlaw S, Kitchen S, Toth P, Makris M.

Blood Coagul Fibrinolysis. 2011 Oct;22(7):565-70. doi: 10.1097/MBC.0b013e3283494b3c.

PMID:
21959588
7.

Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?

Makris M, Van Veen JJ.

Blood Transfus. 2011 Apr;9(2):117-9. doi: 10.2450/2011.0111-10. Epub 2011 Jan 13. No abstract available.

8.

Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.

Makris M, van Veen JJ, Maclean R.

J Thromb Thrombolysis. 2010 Feb;29(2):171-81. doi: 10.1007/s11239-009-0412-5. Review.

PMID:
19882303
9.

The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals.

van Veen JJ, Nokes TJ, Makris M.

Br J Haematol. 2010 Jan;148(1):15-25. doi: 10.1111/j.1365-2141.2009.07899.x. Epub 2009 Sep 22. Review.

PMID:
19775301
10.

Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.

van Veen JJ, Laidlaw S, Swanevelder J, Harvey N, Watson C, Kitchen S, Makris M.

Eur J Haematol. 2009 Mar;82(3):208-12. doi: 10.1111/j.1600-0609.2008.01191.x. Epub 2008 Dec 5.

PMID:
19077049
11.

Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.

van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M.

Thromb Res. 2009 Apr;123(6):895-901. doi: 10.1016/j.thromres.2008.09.011. Epub 2008 Nov 13.

PMID:
19012951
12.

Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.

Gatt A, van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M.

Thromb Haemost. 2008 Aug;100(2):350-5.

PMID:
18690358
13.

Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.

van Veen JJ, Gatt A, Cooper PC, Kitchen S, Bowyer AE, Makris M.

Blood Coagul Fibrinolysis. 2008 Apr;19(3):183-9. doi: 10.1097/MBC.0b013e3282f4bb47.

PMID:
18388496
14.

Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.

van Veen JJ, Hampton KK, Maclean R, Fairlie F, Makris M.

Blood Transfus. 2007 Nov;5(4):204-9. doi: 10.2450/2007.0023-07.

15.

Protein C deficiency screening using a thrombin generation assay - an upgrade.

Gatt A, van Veen JJ, Cooper P, Kitchen S, Makris M.

Thromb Haemost. 2007 Sep;98(3):691-2. No abstract available.

PMID:
17849065
16.

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.

Posthouwer D, Makris M, Yee TT, Fischer K, van Veen JJ, Griffioen A, van Erpecum KJ, Mauser-Bunschoten EP.

Blood. 2007 May 1;109(9):3667-71. Epub 2007 Jan 9.

17.

Misconceptions in thalassaemia diagnosis.

Van Veen JJ, Kelly R, Walker C, Wright J.

Br J Haematol. 2003 Sep;122(6):1025-6. No abstract available.

PMID:
12956776
18.

Cyclophosphamide-induced nail pigmentation.

Srikant M, Van Veen J, Raithatha A, Reilly JT.

Br J Haematol. 2002 Apr;117(1):2. No abstract available.

PMID:
11918527
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk